References
- Summar ML, Koelker S, Freedenberg D, et al. The incidence of urea cycle disorders. Mol Genet Metab. 2013;110(1–2):179–180.
- Sin YY, Baron G, Schulze A, et al. Arginase-1 deficiency. J Mol Med. 2015;93(12):1287–1296.
- Catsburg C, Anderson S, Upadhyaya N, et al. Arginase 1 deficiency: using genetic databases as a tool to establish global prevalence. Orphanet J Rare Dis. 2022;17(1):1–7.
- Asrani KH, Cheng L, Cheng CJ, et al. Arginase I mRNA therapy – a novel approach to rescue arginase 1 enzyme deficiency. RNA Biol. 2018;15(7):914–922.
- Enns GM, Porter MH, Francis-Sedlak M, et al. Perspectives on urea cycle disorder management: results of a clinician survey. Mol Genet Metab. 2019;128(1–2):102–108.
- Iyer R, Jenkinson CP, Vockley JG, et al. The human arginases and arginase deficiency. J Inherit Metab Dis. 1998;21(Suppl 1):86–100.
- Morris SM. Jr. Arginases and arginine deficiency syndromes. Curr Opin Clin Nutr Metab Care. 2012;15(1):64–70.
- GARD. Arginase deficiency. [cited 2021 Dec 7]. https://rarediseases.info.nih.gov/diseases/5840/arginase-deficiency.
- Haberle J, Burlina A, Chakrapani A, et al. Suggested guidelines for the diagnosis and management of urea cycle disorders: first revision. J Inherit Metab Dis. 2019;42(6):1192–1230.
- Sun A, Crombez EA, Wong D, et al. Arginase deficiency. In: Adam MP, Ardinger HH, Pagon RA editors. GeneReviews((R)). Seattle (WA): University of Washington, Seattle; 2000. [updated 2021].
- Blumenfeld AM, Varon SF, Wilcox TK, et al. Disability, HRQoL and resource use among chronic and episodic migraineurs: results from the international burden of migraine study (IBMS). Cephalalgia. 2011;31(3):301–315.
- Dhamane AD, Witt EA, Su J. Associations between COPD severity and work productivity, health-related quality of life, and health care resource use: a cross-sectional analysis of national survey data. J Occup Environ Med. 2016;58(6):e191-197–e197.
- Germain N, Kymes S, Löf E, et al. A systematic literature review identifying associations between outcomes and quality of life (QoL) or healthcare resource utilization (HCRU) in schizophrenia. J Med Econ. 2019;22(5):403–413.
- Pawaskar M, Iglay K, Witt EA, et al. Impact of the severity of hypoglycemia on health – related quality of life, productivity, resource use, and costs among US patients with type 2 diabetes. J Diabetes Complications. 2018;32(5):451–457.
- Huemer M, Carvalho DR, Brum JM, et al. Clinical phenotype, biochemical profile, and treatment in 19 patients with arginase 1 deficiency. J Inherit Metab Dis. 2016;39(3):331–340.
- Diez-Fernandez C, Rüfenacht V, Gemperle C, et al. Mutations and common variants in the human arginase 1 (ARG1) gene: impact on patients, diagnostics, and protein structure considerations. Hum Mutat. 2018;39(8):1029–1050.
- Morales JA, Sticco KL. Arginase deficiency. StatPearls. Treasure Island (FL): StatPearls Publishing; 2022.
- Rajabi F. Updates in newborn screening. Pediatr Ann. 2018;47(5):e187–e190.
- Therrell BL, Currier R, Lapidus D, et al. Newborn screening for hyperargininemia due to arginase 1 deficiency. Mol Genet Metab. 2017;121(4):308–313.
- Haberle J, Boddaert N, Burlina A, et al. Suggested guidelines for the diagnosis and management of urea cycle disorders. J Inherit Metab Dis. 2012;1:S4.
- Schlune A, Vom Dahl S, Häussinger D, et al. Hyperargininemia due to arginase I deficiency: the original patients and their natural history, and a review of the literature. Amino Acids. 2015;47(9):1751–1762.
- Diaz GA, Krivitzky LS, Mokhtarani M, et al. Ammonia control and neurocognitive outcome among urea cycle disorder patients treated with glycerol phenylbutyrate. Hepatology. 2013;57(6):2171–2179.
- Everylife Foundation. The national burden of rare disease study. 2021. [2021 Dec 8]. https://everylifefoundation.org/burden-study/.
- Navarrete-Opazo AA, Singh M, Tisdale A, et al. Can you hear us now? The impact of health-care utilization by rare disease patients in the United States. Genet Med. 2021;23(11):2194–2201.
- Tisdale A, Cutillo CM, Nathan R, et al. The IDeaS initiative: pilot study to assess the impact of rare diseases on patients and healthcare systems. Orphanet J Rare Dis. 2021;16(1):1–8.
- Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–383.
- Polis B, Samson AO. Role of the metabolism of branched-chain amino acids in the development of Alzheimer's disease and other metabolic disorders. Neural Regen Res. 2020;15(8):1460–1470.
- Bösch F, Landolt MA, Baumgartner MR, et al. Health-related quality of life in paediatric patients with intoxication-type inborn errors of metabolism: analysis of an international data set. J Inherit Metab Dis. 2021;44(1):215–225.
- Zeltner NA, Baumgartner MR, Bondarenko A, et al. Development and psychometric evaluation of the MetabQoL 1.0: a quality of life questionnaire for paediatric patients with intoxication-type inborn errors of metabolism. JIMD Rep. 2017;37:27–35.
- Zeltner NA, Landolt MA, Baumgartner MR, et al. Living with intoxication-type inborn errors of metabolism: a qualitative analysis of interviews with paediatric patients and their parents. JIMD Rep. 2017;31:1–9.
- Vasquez-Loarte T, Thompson JD, Merritt JL. Considering proximal urea cycle disorders in expanded newborn screening. Int J Neonatal Screen. 2020;6(4):77.
- Austin PC. An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivariate Behav Res. 2011;46(3):399–424.
- National Organization of Rare Disorders. Rare disease database: arginase-1 deficiency. 2020. [cited 2021 Dec 16]. https://rarediseases.org/rare-diseases/arginase-deficiency/.
- Diaz GA, Longo N, Bubb G, et al. Delays in diagnosis are associated with poor clinical outcomes in patients with arginase 1 deficiency. Ann Neurol. 2019;86:S137–S137.
- Bin Sawad A, Pothukuchy A, Badeaux M, et al. Natural history of arginase 1 deficiency and the unmet needs of patients: a systematic review of case reports. JIMD Rep. 2022. DOI:10.1002/jmd2.12283
- Statista. [cited 2022 Feb 3]. https://www.statista.com/statistics/184432/us-population-with-emergency-room-visits-by-age/.
- Statista. [cited 2022 Feb 3]. https://www.statista.com/statistics/184447/us-population-with-a-hospitalization-by-age/#:∼:text=Hospital%20Stays&text=In%202018%2C%20around%20seven%20percent,hospital%20is%20currently%205.4%20days.
- Statista. [cited 2022 Feb 2]. https://www.statista.com/statistics/492239/us-population-with-usage-of-prescription-drugs-within-one-month/.
- Statista. [cited 2022 Feb 2]. https://www.statista.com/statistics/916781/primary-care-physician-visit-frequency-among-adults-us/.
- Aeglea data on file.